Sagimet Biosciences, Inc. (SGMT)
9.37
+0.25
(+2.74%)
USD |
NASDAQ |
Nov 06, 10:17
Sagimet Biosciences Price : 9.37 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 9.83 | 9.95 | 9.055 | 9.12 | 1.155M |
| Nov 04, 2026 | 10.25 | 10.43 | 9.64 | 9.99 | 756445.0 |
| Nov 03, 2026 | 9.80 | 10.16 | 9.659 | 9.95 | 636838.0 |
| Nov 02, 2026 | 9.92 | 9.97 | 9.615 | 9.69 | 736087.0 |
| Oct 30, 2026 | 10.41 | 10.54 | 9.82 | 9.92 | 989149.0 |
| Oct 29, 2026 | 10.82 | 10.92 | 10.27 | 10.43 | 746454.0 |
| Oct 28, 2026 | 10.32 | 10.76 | 10.26 | 10.74 | 1.236M |
| Oct 27, 2026 | 9.58 | 10.48 | 9.55 | 10.42 | 1.109M |
| Oct 26, 2026 | 9.61 | 9.70 | 9.41 | 9.56 | 767188.0 |
| Oct 23, 2026 | 9.95 | 9.95 | 9.495 | 9.58 | 694947.0 |
| Oct 22, 2026 | 10.00 | 10.15 | 9.628 | 9.95 | 1.007M |
| Oct 21, 2026 | 9.76 | 10.21 | 9.72 | 9.99 | 1.578M |
| Oct 20, 2026 | 8.88 | 10.15 | 8.83 | 9.74 | 2.176M |
| Oct 19, 2026 | 8.24 | 9.005 | 8.15 | 8.86 | 1.685M |
| Oct 16, 2026 | 8.15 | 8.25 | 7.94 | 8.02 | 1.089M |
| Oct 15, 2026 | 7.61 | 8.275 | 7.54 | 8.17 | 1.367M |
| Oct 14, 2026 | 7.78 | 8.00 | 7.51 | 7.545 | 1.985M |
| Oct 13, 2026 | 8.70 | 8.74 | 7.88 | 7.98 | 2.349M |
| Oct 12, 2026 | 8.85 | 9.145 | 8.735 | 8.80 | 1.157M |
| Oct 09, 2026 | 8.84 | 9.05 | 8.78 | 8.93 | 763531.0 |
| Oct 08, 2026 | 8.80 | 8.94 | 8.63 | 8.92 | 1.229M |
| Oct 07, 2026 | 8.65 | 8.97 | 8.598 | 8.88 | 631649.0 |
| Oct 06, 2026 | 8.99 | 8.99 | 8.55 | 8.76 | 896376.0 |
| Oct 05, 2026 | 9.075 | 9.12 | 8.40 | 9.03 | 1.529M |
| Oct 02, 2026 | 9.26 | 9.38 | 8.88 | 9.14 | 1.713M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vanda Pharmaceuticals, Inc. | 3.725 |
| IDEAYA Biosciences, Inc. | 30.88 |
| ACADIA Pharmaceuticals, Inc. | 20.91 |
| Alnylam Pharmaceuticals, Inc. | 158.72 |
| Anika Therapeutics, Inc. | 16.71 |
Price Related Metrics
| Price to Book Value | 2.260 |
| Earnings Yield | -13.68% |
| Market Cap | 578.91M |